NCT06124976View on ClinicalTrials.gov

Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 19, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Urothelial Carcinoma of the Renal Pelvis and UreterTransitional Cell Cancer of the Renal Pelvis and Ureter
Interventions
DRUG

ST-02

ST-02 drug instillation into the upper urinary tract (renal pelvis)

Trial Locations (4)

Unknown

RECRUITING

Vancouver Prostate Centre, Vancouver

RECRUITING

Centre of Applied Urology Research, Nova Scotia Health Authority, Halifax

RECRUITING

UHN - Princess Margaret Cancer Centre, Toronto

R3P 2S8

RECRUITING

Men's Health Clinic, Winnipeg

All Listed Sponsors
lead

University of British Columbia

OTHER